StockGlow

Prescient Therapeutics Limited (PTX.AX)

Develops cancer drugs targeting a protein pathway in blood and solid tumors

0.08+0.01%Healthcare
Compare PTX.AX with
StockGlow Score
76
Leaning Bullish
BearishBullish
1 year ago+76.1%

The outlook

PTX.AX trades at $0.081 and sits solidly above both its 50- and 200-day moving averages, reflecting upward price momentum. The stock sits in the lower half of its 52-week range, roughly 48% of the way between yearly lows and highs. Analyst coverage appears limited based on available data.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range48% of the way from its 52-week low to high
Market cap
$85.2M
52-wk high
0.13
52-wk low
0.04
50-day avg
0.07
200-day avg
0.07
Trailing P/E
—

Similar stocks

IMU.AXImugene Limited$0.09-1.16%ACW.AXActinogen Medical Limited$0.04-4.88%PAB.AXPatrys Limited$0.04-2.50%IMM.AXImmutep Limited$0.05+0.00%OCC.AXOrthocell Limited$0.72+0.70%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy